Member Contact: Barb Ferres
Position: Senior Communications Advisor
Industry: Medtech & Digital
Admedus is a global healthcare company that develops, commercialises and distributes next generation medical technologies and devices.
We have offices in Brisbane, Minneapolis, Zurich and Singapore and a state-of-the-art research and manufacturing facility in Malaga, Australia.
Admedus has four core divisions:
Tissue Engineering – Using our proprietary ADAPT® tissue-processing technology, we are developing a suite of regenerative bio-scaffold products designed for transformative healing in soft tissue repairs.
CardioCel® is our flagship product. It is used to repair congenital heart deformities and complex heart defects, changing patients’ lives for the better around the world. Surgeons at leading heart centres in the US, Europe, and Asia Pacific are using CardioCel® and it has been implanted in thousands of patients to date.
Sales and Distribution – Our medical products team is responsible for distributing and supporting a range of infusion solutions to hospitals in Australia and New Zealand.
Bio-manufacturing – Admedus has a state-of-the-art manufacturing facility in Australia that is used for the global production of our ADAPT suite of products as well as for R&D projects.
Immunotherapies – Working with leading immunologists, including Professor Ian Frazer and his team, we are developing next-generation vaccines for the treatment and prevention of infectious diseases and cancers with an initial focus on Herpes Simplex Virus (HSV-2) and Human papillomavirus (HPV).